Could Drug Delivery Systems Be Enhancers for Therapy against KRAS-driven Cancers?
Crossref DOI link: https://doi.org/10.1134/S2634827624600312
Published Online: 2025-01-08
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khusnutdinov, R. R.
Text and Data Mining valid from 2024-12-01
Version of Record valid from 2024-12-01
Article History
Received: 13 August 2024
Revised: 13 August 2024
Accepted: 21 August 2024
First Online: 8 January 2025
CONFLICT OF INTEREST
: The author of this work declares that he has no conflicts of interest.